Hanne-Line Rabben et al.’s study (13) in gastric cancer revealed SNAP25 as a central regulator in tumor metabolism, with its inhibition leading to improved survival in a gastric cancer mouse model. This evidence concerns the gene SNAP25 and neoplasm.